Stock ZBH * ZIMMER BIOMET HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Zimmer Biomet Holdings, Inc. Mexican S.E.

Equities

ZBH *

US98956P1021

End-of-day quote Mexican S.E.
Other stock markets
 23:00:00 14/05/2024 BST 		5-day change 1st Jan Change
2,015 MXN -3.16% Intraday chart for Zimmer Biomet Holdings, Inc. -.--% +8.91%
06-20 Zimmer Biomet Holdings, Inc. Appoints Devdatt Kurdikar to its Board of Directors CI
06-12 Zimmer Biomet Enters Co-Marketing Deal With RevelAi Health MT

Strengths

  • The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
  • The company returns high margins, thereby supporting business profitability.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses

  • With an enterprise value anticipated at 3.43 times the sales for the current fiscal year, the company turns out to be overvalued.
  • The company is not the most generous with respect to shareholders' compensation.
  • For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
ZIMMER BIOMET HOLDINGS, INC. Stock Zimmer Biomet Holdings, Inc.
+8.91% 22.33B -
ABBOTT LABORATORIES Stock Abbott Laboratories
-5.60% 181B
C+
MEDTRONIC PLC Stock Medtronic plc
-4.45% 101B
C
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-4.15% 67.54B
A
DEXCOM, INC. Stock DexCom, Inc.
-8.63% 45.09B
B-
CENCORA, INC. Stock Cencora, Inc.
+9.70% 44.37B
B-
HOYA CORPORATION Stock Hoya Corporation
+6.13% 40.7B
B+
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+15.22% 29.85B
B
TERUMO CORPORATION Stock Terumo Corporation
+14.80% 24.49B
A-
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-6.46% 23.99B
A-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. ZBH Stock
  4. ZBH * Stock
  5. Ratings Zimmer Biomet Holdings, Inc.